Published in Intensive Care Med on January 01, 1993
Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration. Br J Anaesth (1991) 1.48
Resistance to non-depolarizing neuromuscular blocking agents. Br J Anaesth (1991) 1.10
Atracurium: conception and inception. Br J Anaesth (1983) 0.94
Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. Br J Anaesth (1987) 0.93
Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodialysis. Clin Nephrol (1983) 0.87
Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth (1990) 0.86
Removal of therapeutic drugs by continuous arteriovenous hemofiltration. Arch Intern Med (1985) 0.85
The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology (1984) 0.85
Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth (1984) 0.84
Atracurium infusions in patients with renal failure on an ITU. Anaesthesia (1986) 0.84
Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth (1987) 0.84
Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure. Br J Anaesth (1987) 0.81
Prolonged paralysis following an infusion of alcuronium in a patient with renal dysfunction. Anaesthesia (1987) 0.81
Atracurium infusion in the intensive care unit. Br J Anaesth (1986) 0.80
Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth (1988) 0.80
Metabolic studies in the cat with atracurium: a neuromuscular blocking agent designed for non-enzymic inactivation at physiological pH. Xenobiotica (1982) 0.79
Effect of renal failure on laudanosine excretion in man. Br J Anaesth (1985) 0.78
Use of atracurium and vecuronium in patients with oesophageal varices. Br J Anaesth (1985) 0.78
Studies on muscle relaxants during haemodialysis. Acta Anaesthesiol Scand (1979) 0.78
Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokinet (1990) 0.77
The pharmacokinetics of rocuronium bromide in hepatic cirrhosis. Eur J Anaesthesiol Suppl (1995) 0.77
Pharmacokinetics of 51W89: preliminary data. Acta Anaesthesiol Scand Suppl (1995) 0.75
Muscle relaxants in renal disease. Acta Anaesthesiol Scand Suppl (1994) 0.75